NCT00481637已完成不适用
Tumor Immunity in Neurologically Normal Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 33
- 试验地点
- 1
- 主要终点
- Paraneoplastic neoplastic disease antibody titer, Cytotoxic T Lymphocyte activity, and clinical data in neurologically normal patients with small cell lung cancer and gynecologic tumors, with tumors unrelated to PNDs, and in normal control patients.
研究概览
简要总结
The purpose of this study is to study whether immune cells capable of killing tumors that express proteins associated with paraneoplastic neurologic syndrome (PNS) can be found in small cell lung cancer and ovarian cancer patients. The presence of these cells may play a role in tumor immunity in these patients. The protocol involves neurological examinations and collection of blood.
详细描述
See brief description
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Males and females ages 25 -75
- •If leukapheresis:
- •Hepatitis B surface antigen negative if tested* Hepatitis C antibody negative if tested* HIV antibody negative if tested* Venereal disease reaction level (VDRL) negative if tested* No known IV drug users Hemoglobin > 8.5 White blood cell count > 3,800 Platelets > 120,000 International normalized ratio (INR) < 2 (verified only if clinically indicated)
- •If large blood draw (1/2 to 1 unit) in lieu of leukapheresis:
- •Hepatitis B surface antigen negative if tested* Hepatitis C antibody negative if tested* HIV antibody negative if tested* VDRL negative if tested* No known IV drug users HgB > 10.0 WBC > 3,800 Platelets > 120,000 INR < 2 (verified only if clinically indicated)
排除标准
- •No known neurologic disease
- •No known central nervous system (CNS) metastasis on clinical exam
- •No chemotherapy within 1 month
- •No New York Heart Association class III/IV status
- •No pulmonary disease which limits daily activities
- •No anticoagulation therapy
结局指标
主要结局
Paraneoplastic neoplastic disease antibody titer, Cytotoxic T Lymphocyte activity, and clinical data in neurologically normal patients with small cell lung cancer and gynecologic tumors, with tumors unrelated to PNDs, and in normal control patients.
时间窗: Duration of study
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Analyses of immune status in cancer patientsMalignant tumorJPRN-UMIN000040469Chiba Cancer Center150
已完成
不适用
Research to elucidate the anti-tumor immune responses and develop the combination therapy in solid tumorSolid tumorJPRN-UMIN000040280Osaka International Cancer Institute, Research center80
招募中
不适用
Tumorimmuntherapy associated neurological adverse eventsY57.9Drug or medicament, unspecifiedDRKS00012668Charité Campus Charité Mitte200
已完成
不适用
Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical CancerBenign Tumor of UterusCervical CancerNCT05188716Chuangzhen Chen30
Unknown
不适用
Anti-tumor Specific Immune Response in Head and Neck CancersHead and Neck Squamous Cell CarcinomaNCT02881918Central Hospital, Nancy, France154